Changes in cardiac aldosterone and its synthase in rats with chronicheart failure: an intervention study of long-term treatment with recombinant humanbrain natriuretic peptide

摘要

The physiological mechanisms involved in isoproterenol (ISO)-induced chronic heart failure (CHF) are not fully understood. In this study, we investigated local changes in cardiac aldosterone and its synthase in rats with ISO-induced CHF, and evaluated the effects of treatment with recombinant human brain natriuretic peptide (rhBNP). Sprague-Dawley rats were divided into 4 different groups. Fifty rats received subcutaneous ISO injections to induce CHF and the control group (n=10) received equal volumes of saline. After establishing the rat model, 9 CHF rats received no further treatment, rats in the low-dose group (n=8) received 22.5 μg/kg rhBNP and those in the high-dose group (n=8) received 45 μg/kg rhBNP daily for 1 month. Cardiac function was assessed by echocardiographic and hemodynamic analysis. Collagen volume fraction (CVF) was determined. Plasma and myocardial aldosterone concentrations were determined using radioimmunoassay. Myocardial aldosterone synthase (CYP11B2) was detected by quantitative real-time PCR. Cardiac function was significantly lower in the CHF group than in the control group (P<0.01), whereas CVF, plasma and myocardial aldosterone, and CYP11B2 transcription were significantly higher than in the control group (P<0.05). Low and high doses of rhBNP significantly improved hemodynamics (P<0.01) and cardiac function (P<0.05) and reduced CVF, plasma andmyocardial aldosterone, and CYP11B2 transcription (P<0.05). There were nosignificant differences between the rhBNP dose groups (P>0.05). Elevated cardiacaldosterone and upregulation of aldosterone synthase expression were detected in ratswith ISO-induced CHF. Administration of rhBNP improved hemodynamics and ventricularremodeling and reduced myocardial fibrosis, possibly by downregulating CYP11B2transcription and reducing myocardial aldosterone synthesis.